CHICAGO, Sept. 7, 2023 /PRNewswire/ — Easterseals supports Warrior Call’s efforts to establish a “National Warrior Call Day” on November 12, 2023, and urges Members of Congress to pass a resolution designating the day. “National Warrior Call Day” asks Americans to make a call to a…
“SDS has always strived to design and engineer products that exceed expectations,” said Chief Technology Officer Rich Onofrio, who is a lead Engineering contributor and a co-author of these and all other SDS patents. “Our progress in power management illustrates to our customers and the industry that SDS products are engineered to deliver value.”
Patent US 11,688,414 is the first SDS patent co-authored by Principal Hardware Designer Frank Bachmann, a Northeastern University graduate who started his career with SDS in 2018. “I am honored to be acknowledged by both the USPTO and my colleagues,” said Bachmann. “Patents entail years of research, testing, and collaboration before submission, and the SDS engineering team is constantly exploring new ideas.”
Technical innovations like these are one of the reasons why government organizations, such as the Department of Homeland Security, choose to collaborate with SDS to develop prototypes for new gunshot detection solutions. SDS invites its partners, customers, and competitors to view all of SDS’ gunshot detection innovations on the company’s patents page.
About Shooter Detection Systems
Shooter Detection Systems is the proven leader in gunshot detection. Only SDS delivers Active Shooter Intelligence, our proprietary technology engineered for precision, performance, and saving lives. Our industry-leading product, SDS Indoor Gunshot Detection (formerly Guardian), is SAFETY Act Certified by the U.S. Department of Homeland Security, NPSA rated and “Approved for UK Government Use” in the Catalogue of Security Equipment of the National Protective Security Authority (NSPA), and SL4 Certified by the Australian Government’s Security Construction & Equipment Committee (SCEC). For more information, visit ShooterDetectionSystems.com or call 1-844-SHOT911. Follow SDS’s social channels on Twitter @ShooterDetect and on LinkedIn.
Media Contact
Kendra Noonan, Shooter Detection Systems, 844-746-8911, [email protected], https://www.shooterdetectionsystems.com
SOURCE Shooter Detection Systems
“We are so proud to have received Best Fertility Centre for the 8th year as it recognizes the level of care we strive to provide for our patients,” says Olive Fertility co-director, Dr. Beth Taylor. “The fact that Olive Fertility has among the best pregnancy success rates in Canada is due to our lab, our team of fertility experts and outstanding staff. Everyone at Olive, from the receptionists at the front desk, to the patient-care coordinators, the nurses, the embryologists, and the doctors, strive to make sure that patients have the best experience possible.”
The rate of infertility in Canada has doubled over the last 20 years according to a Stats Canada report, and Olive Fertility has seen a surge of over 30% in the demand for fertility treatment and egg freezing since the pandemic.
“We recommend that anyone over 35 should have a full fertility workup if they haven’t conceived after six months of unprotected intercourse,” says Dr. Taylor. “Age is an important factor, so we want to get a full picture of a person’s fertility soon and then start treatment without delay.”
Recent advances in fertility treatment and preimplantation genetic testing have improved the chances of achieving a pregnancy and having a healthy baby for individuals and couples.
Fertility evaluation and most testing is covered by MSP in British Columbia with a referral from a family physician or a doctor at a walk-in clinic.
Olive would also like to congratulate Acubalance Wellness Centre for receiving the BOV award for Best Naturopathic Clinic. Well done!
Olive Fertility Centre (olivefertility.com) is one Canada’s leading fertility centres with clinics in Vancouver, Surrey, Victoria, and Kelowna offering an award-winning IVF lab, personal care teams, and innovative programs including specialized genetic testing, egg freezing, and prenatal NIPT testing.
Media Contact
Mairi Campbell, Personae Concepts, 1 7788855300, [email protected], Personae Concepts
SOURCE Olive Fertility Centre
NorthCoast 99 winners participated in a rigorous application process that asked for detailed information on how their organization addresses top-performer attraction, development, and retention in the areas of organizational strategy, policies, and benefits; talent attraction, acquisition, and onboarding; employee well-being; employee engagement and talent development; total rewards; and diversity, equity, and inclusion.
“Navigate360 stands for an equitable world and workplace; for inclusivity and respect for people, their views and their practices; for seeing possibilities and building bridges to a world absent of fear; and for kindness, passion, and purpose. Without our dedicated employees, none of this is possible. I am humbled and honored every day to be part of this organization,” Guilbault continued.
“It has been incredible to see the evolution of top workplaces over the last 25 years through the NorthCoast 99 program. While much has changed since the program’s founding in 1999, prioritizing the employee experience has remained a common theme among winning organizations. Year after year, the winners have developed innovative policies and offered exceptional benefits to attract, engage, and retain talented workers. We look forward to recognizing this year’s winners and sharing their success stories,” said ERC President Kelly Keefe.
“Maintaining this recognition is not something we take lightly. Our mission and our employee experience go hand in hand, and we make them top priority every single day,” added Navigate360 Chief Human Resources Officer Alex Teodosio. “We owe our continued success to our dedicated employees. They are the reason for this recognition, and we look forward to attracting, cultivating, and maintaining additional talent as we continue to grow our award-winning team. Our world needs Navigate360 and everyone who supports our meaningful initiatives.”
For more information about current career opportunities at Navigate360, please visit navigate360.com/careers.
About Navigate360
Navigate360 is the premier provider of safety solutions for schools, leading to enhanced student wellbeing. For more than 20 years, our multifaceted, layered approach—providing everything from curricula that support positive behavior and self-image to campus physical safety and personnel training—has focused on incident prevention. Empowering people, schools and communities to stay safe and thrive, Navigate360 serves more than 30,000 schools across the US and more than 14 million students. Recognized as a Certified Great Place to Work, Navigate360 is mission-driven and founded on a data-driven approach to school safety and student wellness.
About ERC
For over 100 years, ERC has been a trusted resource for organizations in Northeast Ohio and around the country. ERC helps leaders build great workplaces through thought leadership, comprehensive data, and HR solutions that include membership, training and professional development, consultative services, and more. ERC is the founder and producer of the NorthCoast 99 awards program and sponsors the ERChealth insurance program for Ohio employers.
Media Contact
Navigate360, Navigate360, (608) 216-7300, [email protected], https://navigate360.com/
SOURCE Navigate360
ECFax for Government installed in the first 40 of 2,000 VA facilities. The sites represent all five examples of VA workplaces throughout the U.S., including inpatient- and outpatient-care, pharmacies, cemeteries and administration.
FALLS CHURCH, Va., Sept. 7, 2023 /PRNewswire-PRWeb/ — Cognosante and Consensus Cloud Solutions, Inc. (NASDAQ: CCSI), the exclusive partnership for federal Enterprise Cloud Fax (ECFax) services, today announced the successful implementation of the government cloud faxing solution at VA facilities across five Initial Operating Capability (IOC) sites across the country. The sites, which were activated over a three-month period, include more than 40 separate facilities and represent all five examples of VA workplaces throughout the U.S., including inpatient- and outpatient-care, pharmacies, cemeteries and administration.
Digital faxes are now being delivered across multiple delivery and integration points within these sites, including multifunctional devices and shared folders, yielding operational efficiencies and reducing the need for standalone hardware in each location.
A critical business technology, ECFax was customized to meet stringent government technical and security requirements while providing a truly universal and robust solution to support Veterans, as well as VA care providers and staff. This service will be available in more than 2,000 VA facilities across the United States.
Cognosante, the prime contractor and program lead, will continue to implement ECFax digital fax services, which includes installation, onboarding, reporting and training, throughout all VA settings. ECFax is the first cloud-based digital faxing solution approved for use by VA and enables the transformation, enhancement and secure exchange of digital information.
“For years we have supported VA’s commitment to modernizing its services with cloud-based technologies,” says Erick Peters, Cognosante’s Chief Technology Officer. “Working with Consensus on the ECFax program is a natural extension of our promise to VA to help improve Veteran care by streamlining administrative processes.”
The technological advancement of VA’s cloud faxing system will accelerate the department’s ability to deliver a variety of services to the country’s 16.5 million Veterans, while enabling interoperability and secure data exchange between all VA facilities throughout the nation.
“We are proud to successfully complete this first major milestone with Cognosante and VA as we continue to deliver on our objective of supporting government agencies across the U.S. by providing best-in-class cloud fax technologies to improve document exchange processes,” stated Scott Turicchi, Consensus Cloud Solutions’ Chief Executive Officer.
Developed specifically for state and federal government use, ECFax streamlines workflow processes, while reducing administrative burden and eliminating the need for outdated, paper-based faxing. Additional benefits include:
Hosted on Amazon Web Services’ GovCloud, ECFax provides on-demand, automatic scalability to hundreds of millions of pages per month. Visit the online FedRAMP Marketplace to learn more about ECFax for Government.
About Cognosante
Cognosante is a mission-driven technology company delivering innovative and transformative solutions that improve the health and safety of Americans. With more than a decade of experience working with federal and state government agencies, we aim to expand access to care, improve care delivery, deliver solutions addressing social determinants of health, and ensure safety and security through multi-faceted technology and customer experience (CX) solutions. Our broad range of capabilities includes enterprise IT and cloud, data science, telehealth, interoperability, public health surveillance, clinical performance, eligibility and enrollment, and consumer engagement. For more information, visit http://www.cognosante.com.
About Consensus Cloud Solutions
Consensus Cloud Solutions, Inc. (NASDAQ: CCSI) is one of the world’s largest digital fax providers and a trusted global source for the transformation, enhancement and secure exchange of digital information. We leverage our 25-year history of success by providing advanced data transformation solutions for regulated industries such as healthcare, finance, legal, insurance, real estate and manufacturing, as well as technology for the state and federal government. Our solutions consist of cloud faxing; digital signature; interoperability; intelligent data extraction using natural language processing and artificial intelligence; robotic process automation; and workflow enhancement. We also offer a powerful connectivity and integration platform for healthcare providers. Our solutions can be combined with managed services for optimal outcomes. For more information about Consensus, visit consensus.com and follow @ConsensusCS on Twitter to learn more.
ECFax Media Relations:
Stephanie Kinsey
[email protected]
240-904-4517
Christine Duval
[email protected]
781-519-8539
Media Contact
Stephanie Kinsey, Cognosante, 2409044517, [email protected], www.cognosante.com
Christine Duval, Consensus, 781-519-8539, [email protected], www.consensus.com
SOURCE Cognosante
“BlackCloak is driven by the mission to uncover and address cybersecurity vulnerabilities facing our members, no matter the location,” said Dr. Chris Pierson, BlackCloak Founder and CEO. “Our recent penetration testing for several of our clients at this location has underscored the need for continuous vigilance and proactive security measures. While this island nation is synonymous with luxury and relaxation, our findings serve as a stark reminder that even the most serene environments are not immune to threats.”
Key Discoveries:
“After conducting a vulnerability assessment of an individual’s on-site residence, we uncovered a critical vulnerability that impacted every resident and other critical infrastructure. We reported the vulnerability to the proper channels and ensured the primary attack vector was mitigated. said Daniel Floyd, BlackCloak Chief Information Security Officer. “We are committed to partnering with the community, its proprietors and stakeholders to fortify their personal cybersecurity and ensure they can enjoy peace of mind.”
Media Contact
Mike Sias, BlackCloak, 1 4087574362, [email protected], www.blackcloak.io
SOURCE BlackCloak
NORTH BETHESDA, Md., Sept. 7, 2023 /PRNewswire-PRWeb/ — The International Society for Pharmaceutical Engineering (ISPE) is pleased to announce the results of our 2023–2024 International Board of Directors election. The election was run by an independent third party, Intelliscan, Inc., which provided ISPE with the final audited results.
The Board is responsible for the governance and strategic direction of the Society and will assume their elected positions at the 2023 ISPE Annual Meeting & Expo, taking place in Las Vegas, NV, USA, and virtually from 15–18 October. The following pharmaceutical industry leaders have been elected to positions on the 2023–2024 ISPE International Board of Directors.
Officers:
Directors Elected to a Second Term:
New Director:
Continuing Board Members:
The following Directors were elected in 2022 to serve a two-year term and will continue their service on the Board.
Emerging Leader Representative, Ex Officio:
Board Members Completing Service:
The following individuals will complete their Board service and end their term at the 2023 ISPE Annual Meeting & Expo. ISPE thanks these individuals for their dedication and commitment to the organization.
Visit ISPE Board of Directors Election Results and delve into comprehensive biographies of all the esteemed members of the ISPE’s International Board of Directors.
About ISPE
The International Society for Pharmaceutical Engineering (ISPE) is a global nonprofit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 20,000+ members of ISPE provide solutions to complex pharmaceutical industry challenges through innovation, member and workforce development, and technical, regulatory, and compliance collaborations in more than 120 countries worldwide. Founded in 1980, ISPE has its worldwide headquarters and training center in North Bethesda, Maryland, USA, and its operations center in Tampa, Florida, USA. For more information, visit ISPE.org.
Media Contact
Brad Ettinger, VP Marketing & Communications, ISPE, 3013649203, [email protected], www.ispe.org
SOURCE ISPE
Grants for the year ahead have been awarded in the form of two Post-Doctoral Fellowships, seven Research Grants, two Diversity in Parkinson’s Disease Research grants, eight APDA Centers for Advanced Research, and one George C. Cotzias Memorial Fellowship, APDA’s most prestigious award.
For the fourth year in a row, APDA is awarding a specialized grant to two researchers focused on diverse and under-represented communities. APDA created the first-of-its-kind Diversity in Parkinson’s Disease Research Grant in 2019 to encourage and support researchers who are committed to diversity-focused research so we can learn more about how the disease affects different populations and ultimately better serve people with PD from all communities.
All APDA grants are awarded through a competitive application process and reviewed by APDA’s Scientific Advisory Board (SAB) which is comprised of scientists with a wide array of backgrounds and expertise in all areas relevant to PD research. The SAB meets annually to review all grant proposals and set the scientific direction of APDA’s annual research investment. “Once again our Scientific Advisory Board reviewed many excellent applications and had to make difficult decisions about whom to fund” states Rebecca Gilbert, MD, PhD, and Chief Scientific Officer, APDA. “I am very proud of the many promising projects that we are funding this year.”
The 2023-2024 APDA Research Grants
The George C. Cotzias Fellowship is APDA’s most prestigious grant and is awarded to a young physician-scientist with exceptional promise who is establishing a career in research, teaching, and clinical services relevant to Parkinson’s. The award spans three years and is designed to fund a long-range project focused on PD. This year’s awardee is:
RNA regulation in Parkinson’s disease and levodopa-induced dyskinesia
APDA Diversity in Parkinson’s Disease Research Grants are one-year grants to study the health inequities and/or differences among under-studied PD communities, across the spectrum of ethnicity, ancestry, geography, socioeconomic conditions, and gender. This year’s awardees are:
Low utilization of deep brain stimulation (DBS) therapy among minoritized individuals with Parkinson’s disease
Physical activity among Latino/a people with Parkinson’s disease and their care partners
Post-Doctoral Fellowships are awarded to support post-doctoral scientists who recently completed their PhD work and whose research holds promise to provide new insights into the pathophysiology, etiology, and treatment of PD. This year’s awardees are:
The neurobiological basis of Parkinson’s disease clinical subtypes
Enhancing neuronal resilience to neurodegeneration via the epigenetic-metabolic axis
Research Grants are awarded to investigators performing innovative PD research at major academic institutions across the United States. This year’s awardees are:
Investigating the role of progranulin in synucleinopathy
Cdk5 inhibition as a protective mechanism against environmental toxicant induced Parkinson’s disease
Mechanisms of SARS-CoV-2 infection induced dopamine neuron damage
Stimulation induced evoked potentials for guided intra and post-operative functional mapping
Using IPSC models to interrogate Inflammasome-mediated pathogenesis in Parkinson’s Disease
The role of Lamp1 in age-related neurodegenerative diseases
Mechanisms of posterior cortical circuit dysfunction and cognitive impairment in a mouse model of PD
In addition, continued funding was granted for eight APDA Centers for Advanced Research to support various programs including research trainees, clinical fellowship programs, early-stage discovery programs and later-stage clinical translation. These Centers facilitate research that is at the forefront of investigation into the causes, treatments and ultimately the cure for PD. The current APDA Centers for Advanced Research are:
“We are confident that the projects that we are currently funding will have a high impact on further understanding Parkinson’s disease,” states Chambers. “This work is only possible because of the support of our generous APDA donors.”
Learn more about these grantees and the exciting work they are doing and browse all APDA-funded research by visiting http://www.apdaparkinson.org/research/what-we-fund/.
Researchers and physicians who are interested in applying for APDA funding can visit http://www.apdaparkinson.org/research for details on the 2024-2025 funding opportunities. Letters of Intent for the 2024-2025 grant cycle can be submitted starting September 28, 2023, with a deadline of December 2, 2023.
Those who want to support APDA’s critical research with a donation can do so by visiting http://www.apdaparkinson.org/donate or mailing a check payable to APDA to: APDA, PO Box 61420, Staten Island, NY 10306.
The American Parkinson Disease Association (APDA) is a nationwide grassroots network dedicated to fighting Parkinson’s disease (PD) and works tirelessly to help the approximately one million people in the United States with PD live life to the fullest in the face of this chronic, neurological disorder. Founded in 1961, APDA has raised and invested more than $252 million to provide outstanding patient services and educational programs, elevate public awareness about the disease, and support research designed to unlock the mysteries of PD and ultimately put an end to this disease. To join us in the fight against Parkinson’s disease and to learn more about the support APDA provides nationally through our network of Chapters and Information & Referral (I&R) Centers, as well as their national Research Program and Centers for Advanced Research, please visit http://www.apdaparkinson.org.
Media Contact
Eloise Caggiano, American Parkinson Disease Association (APDA), 718.737.8151, [email protected], www.apdaparkinson.org
SOURCE American Parkinson Disease Association (APDA)
DUBLIN, Sept. 6, 2023 /PRNewswire/ — In light of the recent European Medicines Agency’s safety committee recommendation against the use of topiramate-containing medicines in pregnant women, the importance of rigorous pharmacovigilance practices has never been more evident. The…
2. The experience of the Metaverse x Radio x Scents
The new metaverse experience presented by transcosmos applies V-air, a web-based metaverse developed by Urth inc. (Chief Executive Officer: Hiroki Tanaka). In the virtual space, transcosmos reproduced a radio studio which actually exists in TOKYO FM and a jungle in Cambodia, a place with a special connection with the guests. In addition, to link the real world with the metaverse, transcosmos ran a project to design an interface with the five senses. Using Smell Market, a smell NFT developed by Horizon Inc., a company which specializes in digitalizing scents, transcosmos added the sense of smell on top of vision that a 3D space metaverse brings and the sound of radio. By combining the three senses, transcosmos aimed to make the experience more immersive and strengthen the feeling of unity that only a public recording session can offer. Listeners invited to the recording session enjoyed experiencing the metaverse world, the smell of jungle and the scent of honey, not to mention the interesting conversation between Masataka Matsutoya and Pony Ogata.
In answering the program’s signature question, “What will the world look like in 2050?” during the recording, the personality Masataka Matsutoya said “The metaverse will look much more real. And everyone will be using the metaverse more and more. Perhaps more than 50% of people will be doing something in the metaverse world.” And the guest Pony Ogata said “I was a little surprised. I mean, amazed by what-do-you-call-it, a polygon? The recent 3D image.” Both showed keen interest in the potential of the metaverse. The program received much positive feedback, like, “I’m so excited watching the radio booth! Really impressed!” and “I think it was an interesting try. The scents matched the virtual world really well. I felt as if I was actually on a jungle tour.” Most of the audience said that through this metaverse experience, they saw new possibilities that radio brings.
3. Future plan
The metaverse space with a radio booth and jungle used for the recording will be open for public access for a limited period from 5:30 pm, Friday August 25 to Saturday September 30. With the aim of creating new communication experiences, transcosmos will not only build metaverse spaces but also promote a range of metaverse initiatives with partner companies, combining the metaverse with radio, scents, and more.
4. About “Can I ask something a bit weird by Masataka Matsutoya” presented by transcosmos
Time: 17:30-17:55 on Fridays
Broadcasting stations: Japan FM Network 38 stations including TOKYO FM
Host: Masataka Matsutoya
Content: A music producer Masataka Matsutoya welcomes and delves into guests from diverse fields to discover their hidden charm.
SNS: https://www.instagram.com/masataka_tfm/
URL: https://audee.jp/program/show/44056
*1 Source: Market research by Tokyo FM Broadcasting Co., Ltd. (at the time of this press release)
About transcosmos inc.
transcosmos launched its operations in 1966. Since then, we have combined superior “people” with up-to-date “technology” to enhance the competitive strength of our clients by providing them with superior and valuable services. transcosmos currently offers services that support clients’ business processes focusing on both sales expansion and cost optimization through our 172 bases across 28 countries/regions with a focus on Asia, while continuously pursuing Operational Excellence. Furthermore, following the expansion of e-commerce market on the global scale, transcosmos provides a comprehensive One-Stop Global E-Commerce Services to deliver our clients’ excellent products and services to consumers in 46 countries/regions around the globe. transcosmos aims to be the “Global Digital Transformation Partner” of our clients, supporting the clients’ transformation by leveraging digital technology, responding to the ever-changing business environment. Visit us here https://www.trans-cosmos.co.jp/english/
Media Contact
transcosmos inc., transcosmos inc., +81-3-6709-2251, [email protected], https://www.trans-cosmos.co.jp/english/
SOURCE transcosmos inc.
